Clinical trials

  • DIVARASIB for Non-small cell lung cancer (non-squamous), KRAS G12C-mutated, advanced or metastatic
  • NIVOLUMAB for Pancreatic cancer | Borderline resectable pancreatic cancer | Locally advanced pancreatic cancer | Metastatic pancreatic cancer
  • Lutetium Lu-177; ABY-271 for HER2-positive metastatic breast cancer
  • OSIMERTINIB for EGFR-mutated non-small cell lung cancer
  • Tislelizumab for Esophageal squamous cell carcinoma | Advanced esophageal squamous cell carcinoma
  • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE for Non-small cell lung cancer
  • Piperacillin (as piperacillin sodium / piperacillin monohydrate) and Tazobactam (tazobactam sodium) for Chronic obstructive pulmonary disease | Cystic fibrosis
  • Clinical trial in Advanced solid tumors
  • Citicoline for Delirium | Cognitive decline | Hip fracture (proximal femur)
  • DERMATOPHAGOIDES FARINAE ALLERGOID, GLUTARALDEHYDE-MODIFIED; DERMATOPHAGOIDES PTERONYSSINUS ALLERGOID, GLUTARALDEHYDE-MODIFIED; LEPIDOGLYPHUS DESTRUCTOR, POLYMERISED EXTRACT for Allergic rhinitis/rhinoconjunctivitis|Allergic asthma|House dust mite allergy
  • umeclidinium bromide, vilanterol for Chronic obstructive pulmonary disease | Heart failure (left ventricular ejection fraction 35-50%) | Heart failure (left ventricular ejection fraction 35-55%)
  • RITLECITINIB TOSILATE for Hidradenitis suppurativa